Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Main subject
Publication year range
1.
Acta Gastroenterol Latinoam ; 43(4): 308-11, 2013 Dec.
Article in Portuguese | MEDLINE | ID: mdl-24516958

ABSTRACT

Chronic infection by the hepatitis C virus (HCV) is one of the leading causes of chronic liver disease with an estimate worldwide prevalence of over 200 million people. Acute hepatitis C infection is usually asymptomatic and rarely identified in clinical practice, leading to chronic infection in about 80% of all cases. However, when symptomatic, only about 50% of acute infections progress to chronicity. Correctly identifying acute HCV infection is of paramount importance once it presents itself as an unique treatment opportunity with sustained virological response of about 90%, which is very distant from the 30% to 80% of sustained virological response achieved with standard chronic HCV treatment. The authors present four cases of acute HCV infection. There was spontaneous viral clearance in two pa- tients at week 12 of follow-up. In one case viral RNA was positive at week 12 but sustained virological response was eventually achieved after peginterferon alpha2a monotherapy.


Subject(s)
Hepatitis C/diagnosis , Acute Disease , Adult , Antiviral Agents/therapeutic use , Female , Hepacivirus/genetics , Hepacivirus/immunology , Hepatitis C/drug therapy , Hepatitis C Antibodies/blood , Humans , Interferon-alpha/therapeutic use , Male , RNA, Viral
2.
Acta gastroenterol. latinoam ; 43(4): 308-11, 2013 Dec.
Article in Spanish | BINACIS | ID: bin-132724

ABSTRACT

Chronic infection by the hepatitis C virus (HCV) is one of the leading causes of chronic liver disease with an estimate worldwide prevalence of over 200 million people. Acute hepatitis C infection is usually asymptomatic and rarely identified in clinical practice, leading to chronic infection in about 80


of all cases. However, when symptomatic, only about 50


of acute infections progress to chronicity. Correctly identifying acute HCV infection is of paramount importance once it presents itself as an unique treatment opportunity with sustained virological response of about 90


, which is very distant from the 30


to 80


of sustained virological response achieved with standard chronic HCV treatment. The authors present four cases of acute HCV infection. There was spontaneous viral clearance in two pa- tients at week 12 of follow-up. In one case viral RNA was positive at week 12 but sustained virological response was eventually achieved after peginterferon alpha2a monotherapy.


Subject(s)
Hepatitis C/diagnosis , Acute Disease , Adult , Antiviral Agents/therapeutic use , Female , Hepacivirus/genetics , Hepacivirus/immunology , Hepatitis C/drug therapy , Hepatitis C Antibodies/blood , Humans , Interferon-alpha/therapeutic use , Male , RNA, Viral
3.
Acta gastroenterol. latinoam ; Acta gastroenterol. latinoam;43(4): 308-11, 2013 Dec.
Article in Spanish | LILACS, BINACIS | ID: biblio-1157396

ABSTRACT

Chronic infection by the hepatitis C virus (HCV) is one of the leading causes of chronic liver disease with an estimate worldwide prevalence of over 200 million people. Acute hepatitis C infection is usually asymptomatic and rarely identified in clinical practice, leading to chronic infection in about 80


of acute infections progress to chronicity. Correctly identifying acute HCV infection is of paramount importance once it presents itself as an unique treatment opportunity with sustained virological response of about 90


, which is very distant from the 30


of sustained virological response achieved with standard chronic HCV treatment. The authors present four cases of acute HCV infection. There was spontaneous viral clearance in two pa- tients at week 12 of follow-up. In one case viral RNA was positive at week 12 but sustained virological response was eventually achieved after peginterferon alpha2a monotherapy.


Subject(s)
Hepatitis C/diagnosis , Adult , Hepatitis C Antibodies/blood , Antiviral Agents/therapeutic use , Acute Disease , Female , Hepacivirus/genetics , Hepacivirus/immunology , Hepatitis C/drug therapy , Humans , Interferon-alpha/therapeutic use , Male , RNA, Viral
SELECTION OF CITATIONS
SEARCH DETAIL